Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.
NCT05802888 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 260
Last updated 2023-04-07
Summary
The researchers collect H.pylori-positive patients who need rescue therapy from the outpatient clinic. The subjects were randomized to receive a dose and frequency of tetracycline 500mg tid or qid of bismuth quadruple eradication therapy. 6-8 weeks after treatment, the subjects will re-take the 13C-urea breath test. Calculate the eradication rates, adverse reaction rates and patient compliance of each group.
Conditions
- Helicobacter Pylori Infection
Interventions
- DRUG
-
Tetracycline 500mg tid
Amoxicillin 1000mg bid +Tetracycline 500mg tid +Bismuth+Esomeprazole 40mg bid
- DRUG
-
Tetracycline 500mg qid
Amoxicillin 1000mg bid +Tetracycline 500mg qid +Bismuth+Esomeprazole 40mg bid
Sponsors & Collaborators
-
Peking University Care Luzhong Hospital
collaborator OTHER -
Zibo Central Hospital
collaborator OTHER_GOV -
Yuncheng County Hospital of Traditional Chinese Medicine
collaborator UNKNOWN -
Taierzhuang District People's Hospital
collaborator OTHER -
People's Hospital of Zhengzhou University
collaborator OTHER -
Shandong University
lead OTHER
Principal Investigators
-
Yanqing Li, Ph.D · Qilu Hospital of Shandong University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-12
- Primary Completion
- 2024-06-15
- Completion
- 2024-06-15
Countries
- China
Study Locations
More Related Trials
-
Doxycycline for Helicobacter Pylori Rescue Treatment
NCT05874570 ·Status: RECRUITING ·Phase: PHASE4
-
The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical Trial
NCT05586113 ·Status: UNKNOWN ·Phase: PHASE4
-
Rescue Therapy for Helicobacter Pylori Eradication Treatment
NCT04531059 ·Status: COMPLETED ·Phase: PHASE4
-
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days
NCT04901117 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection
NCT03779087 ·Status: COMPLETED ·Phase: NA
-
Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p
NCT05850117 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
NCT02490839 ·Status: COMPLETED ·Phase: PHASE4
-
Minocycline for Helicobacter Pylori Rescue Treatment
NCT06332599 ·Status: COMPLETED
-
The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection
NCT05620589 ·Status: UNKNOWN
-
Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin
NCT04122287 ·Status: UNKNOWN ·Phase: PHASE4
-
14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection
NCT05438550 ·Status: UNKNOWN ·Phase: PHASE4
-
P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
NCT07285096 ·Status: RECRUITING
-
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
NCT07167511 ·Status: COMPLETED
-
Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains
NCT06687473 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication
NCT03897244 ·Status: COMPLETED ·Phase: PHASE4
-
High Dose Amoxicillin Versus Tetracycline as Second-line Treatment of Resistant Helicobacter Pylori Infection
NCT02175927 ·Status: COMPLETED ·Phase: PHASE4
-
Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
NCT06168084 ·Status: COMPLETED ·Phase: PHASE4
-
Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection
NCT02978157 ·Status: COMPLETED ·Phase: NA
-
High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection
NCT06561698 ·Status: RECRUITING ·Phase: PHASE4
-
Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
NCT04558502 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies
NCT03779074 ·Status: COMPLETED ·Phase: PHASE3
-
14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection
NCT06687499 ·Status: COMPLETED ·Phase: PHASE4
-
Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy
NCT02894268 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin
NCT06351891 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment
NCT05250050 ·Status: UNKNOWN ·Phase: PHASE4